ONP’s Revised MaPP Routes Steps For Investigational New Drug Applications
This article was originally published in The Tan Sheet
Executive Summary
FDA's Office of Nonprescription Products outlines oversight and workflow procedures for filing investigational new drug applications in a newly issued Manual of Policies and Procedures released by the Center for Drug Evaluation and Research